Gastrointestinal symptoms and bowel habits in 53 046 healthy Danish blood donors: a nationwide cross-sectional study [0.03%]
丹麦五万三千名健康献血者胃肠症状和排便习惯的全国性横断面研究
Anne Karmisholt Grosen,Jens Kjærgaard Boldsen,Susan Mikkelsen et al.
Anne Karmisholt Grosen et al.
Objective: To characterise gastrointestinal symptoms and bowel habits in healthy blood donors and explore symptom phenotypes and their associated factors. ...
Health-related quality of life in patients with liver cirrhosis following adjunctive nurse-based care versus standard medical care: a pragmatic, multicentre, randomised controlled study [0.03%]
基于护理的辅助治疗与常规医疗对肝硬化患者生命质量影响的实效性多中心随机对照研究
Maria Hjorth,Daniel Sjöberg,Anncarin Svanberg et al.
Maria Hjorth et al.
Objectives: Patients have difficulties in understanding how to manage their liver cirrhosis. This highlights a need for support in comprehending health-related information, which remains largely lacking within liver cirrh...
Randomized Controlled Trial
BMJ open gastroenterology. 2025 Jan 31;12(1):e001694. DOI:10.1136/bmjgast-2024-001694 2025
Monitoring for 5-aminosalicylate nephrotoxicity in adults with inflammatory bowel disease: prognostic model development and validation using data from the Clinical Practice Research Datalink [0.03%]
使用临床实践研究数据链的数据开发和验证监测炎症性肠病成人患者5-氨基水杨酸肾毒性的预后模型
Abhishek Abhishek,Georgina Nakafero,Tim Card et al.
Abhishek Abhishek et al.
Objective: To develop and validate a prognostic model for risk-stratified monitoring of 5-aminosalicylate nephrotoxicity. Methods: This...
Prevalence of resistance-associated substitutions (RAS) in hepatitis C virus in the Former Soviet Union countries [0.03%]
前苏联国家地区的丙型肝炎病毒耐药相关变异（RAS）流行情况
Aidana Mustafa,Salima Davlidova,Syed Hani Abidi et al.
Aidana Mustafa et al.
Objective: The emergence of resistance-associated substitutions (RASs) poses a significant challenge to the effective treatment of hepatitis C virus (HCV) infection using direct-acting antivirals. This study's objective w...
Triglyceride lowering in patients with different severities of hypertriglyceridaemia-associated acute pancreatitis: secondary analysis of a multicentre, prospective cohort study [0.03%]
不同严重程度高甘油三酯血症急性胰腺炎患者的甘油三酯降低水平：一项多中心前瞻性队列研究的二次分析
Xiang Luo,Xiaoling Li,Xiaoyan Lai et al.
Xiang Luo et al.
Objective: It is controversial whether rapid lowering of triglyceride (TG) levels is associated with clinical benefits in patients with hypertriglyceridaemia-associated acute pancreatitis (HTG-AP). In particular, patients...
Multicenter Study
BMJ open gastroenterology. 2025 Jan 22;12(1):e001620. DOI:10.1136/bmjgast-2024-001620 2025
Current and projected incidence rates of pancreatic cancer in 43 countries: an analysis of the Cancer Incidence in Five Continents database [0.03%]
5大洲癌症登记数据库中43个国家目前和预测的胰腺癌发病趋势分析
Songting Shou,Rui Liu,Jie He et al.
Songting Shou et al.
Objective: The aetiology of pancreatic cancer is complex, and there is limited research on its incidence. We aimed to investigate the incidence trends of pancreatic cancer in 43 countries and predict trends up to 2030. ...
Optimising fatigue, abdominal pain and faecal incontinence in people with inflammatory bowel disease (IBD-BOOST Optimise): feasibility study of a checklist and algorithm for initial nurse-led management [0.03%]
优化炎症性肠病患者的疲劳、腹痛和排便失禁：初步护理为主的管理和算法检查表的可行性研究(I BD-BOOST 优 化)
Imogen Stagg,Ailsa Hart,Fionn Cléirigh Büttner et al.
Imogen Stagg et al.
Objective: Many people with inflammatory bowel disease (IBD) experience fatigue, pain and faecal incontinence that some feel are inadequately addressed. It is unknown how many have potentially reversible medical issues un...
Real-world analysis of acamprosate use in patients with cirrhosis and alcohol-associated hepatitis [0.03%]
有关乙醇相关性肝炎和肝硬化的患者使用acamprosat的现实研究分析
Christopher Oldroyd,Jonathan Wood,Michael Allison
Christopher Oldroyd
Objective: Preventing return to alcohol is of critical importance for patients with alcohol-related cirrhosis and/or alcohol-associated hepatitis. Acamprosate is a widely used treatment for alcohol use disorder (AUD). We ...
Economic evaluation of proton pump inhibitors in patients with gastro-oesophageal reflux disease: a systematic review [0.03%]
胃食管反流病患者的质子泵抑制剂经济评价：系统综述
Seidamir Pasha Tabaeian,Sajad Moeini,Aziz Rezapour et al.
Seidamir Pasha Tabaeian et al.
Objectives: Our aim was to systematically review the cost-effectiveness of proton pump inhibitor (PPI) therapies and surgical interventions for gastro-oesophageal reflux disease (GORD). ...
Parallel randomised trial testing community fibrosis assessment for suspected non-alcoholic fatty liver disease: outcomes from LOCATE-NAFLD [0.03%]
社区纤维化评估疑似非酒精性脂肪肝病的平行随机试验：LOCATE-NAFLD的结果
Ruth Tulleners,Adrian Barnett,James O&#x;Beirne et al.
Ruth Tulleners et al.
Objective: Non-alcoholic fatty liver disease (NAFLD) is estimated to affect a third of Australian adults, and its prevalence is predicted to rise, increasing the burden on the healthcare system. The LOCal Assessment and T...
Randomized Controlled Trial
BMJ open gastroenterology. 2024 Dec 20;11(1):e001418. DOI:10.1136/bmjgast-2024-001418 2024